Quantitative analysis of DAI, histopathology, various inflammatory indicators, and MPO and TJ showed that oxymatrine exerts an antioxidant and anti-inflammatory effect in IBD mice, thereby reducing intestinal inflammation, strengthening barrier protection, and regulating intestinal flora, aiming to improve IBD symptoms. This evidence concerns the gene MPO and inflammatory bowel disease.